BUSINESS● LOW2h ago · Oct 29, 2026, 10:31 AM
Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength
CNBC · north america
Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS18m agoInitial jobless claims unexpectedly slip to 194K in past weekSeeking Alpha TechBUSINESS18m agoRapide Group signs LoI to acquire Indonesian Commodities BusinessSeeking Alpha Tech